PharmaVOICE - 
September 2002
Purchase Issue

In Every Issue
Talent Pool
Pharma POOL Margaret M.FORAN Chuck HARDWICK Pat KELLY Ian READ [...]
By
E-Media
NEW ELECTRONIC AND WEB BASED APPLICATIONS, SITES, AND TECHNOLOGIES MDchoice.com [...]
By
What’s New
NEW HEALTHCARE RELATED PRODUCTS, SERVICES, AND COMPANIES Dorland Sweeney Jones [...]
By
PharmaTrax
Teams and effective practices that drive corporate growth. “Successful new [...]
By
For Art’s Sake
CREATIVE review The mind often plays tricks on the memory. [...]
By
Pharma Outlet
Sy Syms, founder of the offprice designer clothing chain that [...]
By

Jack Trout

What’s on your mind: Opinions
A “Free Economy?” I, for one, am getting sick and [...]
By
Raise Your Voice: Letters
Worth the price of admission For years, economic developers have [...]
By
Letter from the Editor
PUBLISHER Lisa Banket EDITOR Taren Grom CREATIVE DIRECTOR Marah Walsh [...]
By

Taren Grom, Editor

On The Cover

Industry Heal Thyself
The right MEDICINE TREWHITT. More than a year ago, key members of PhRMA’s executive board identified that there was a need to revisit the guidelines and make some improvements to eliminate the periodic complaints and allegations about the practices of sales representatives and their relationships with doctors. These new comprehensive marketing guidelines went into effect [...]
By

Taren Grom, Editor

Features

John T. Spitznagel — A New Horizon
PharmaVOICE EARLY ON IN HIS CAREER,JOHN SPITZNAGEL SET HIS SIGHTS ON ONE DAY RUNNING A HEALTHCARE COMPANY. IN MAY 2002, AS CHAIRMAN AND CEO OF ESP PHARMA, HIS VISION BECAMEAREALITYONCEAGAIN. Mr. Spitznagel already has proven that he has what it takes to drive a company to success, having engineered the dramatic turnaround of Roberts Pharmaceutical [...]
By

Kim Ribbink

Finding a Spot for Frova
Instead of trying to conquer the entire antimigraine market, Frova will stake its claim by focusing on a niche market segment that can benefit from the drug’s unique halflife and superior safety profile Frova isn’t the drug for every migraine patient. The marketers of the latest triptan to enter the antimigraine market — UCB Pharma [...]
By

Elisabeth Pena

The IRS vs. Independent Contractors
Many pharmaceutical companies are now using independent contractors in increasing numbers; in many cases, these contractors are former employees. What started off as a trickle a few years ago has become a torrent. Quite often, former employees — whether they left voluntarily or not — end up back at their old companies, sitting at their [...]
By

Andrew E. Schultz

The Value of Innovation
BY ALEX ROBINSON Let’s stop complaining about spending on prescription drugs,” Alan Holmer, president of the Phar maceutical Research and Manufacturers of Ameri ca (PhRMA) told an audience in April. “In fact, let’s hope that prescription drug spending goes up — not down.” Critics are quick to point out that spending on prescription drugs has [...]
By

Alex Robinson

Manufacturing for Bio Capacity
George Coleman President, Biomedex Inc., Spokane, Wash.; Biomedex specializes in a broad spectrum of contract manufacturing services for bio- pharmaceutical clients, from regulatory compliance to aseptic filling, to validation, to cleanroom sanitizing agents, to quality assurance, to component cleaning David Fox Partner, food, drug, medical device and agricultural group, Hogan & Hartson LLP, Washington, D.C.; [...]
By

Denise Myshko

FEEDBACK